I explore historical and modern perspectives on growing older.
Historical Perspective: Dr. Jean Astruc
The discussion begins with insights from Dr. Jean Astruc, a physician from the era of Louis XIV [00:31].
Aging as Illness: Astruc viewed aging as an unavoidable illness and suggested the goal should be to make it a long one [00:50].
The “Succulent” Lifestyle: His historical advice for a good old age included an abundant diet, wine, liquor, minimal exercise, and plenty of sleep—moving primarily from “bed to table and back to bed” [01:32].
Contextual Reality: The video notes that this advice was aimed at the privileged few, as the general life expectancy at the time was under 30 [01:44].
Visible Signs and Social Management
I touch on the physical realities of aging and how society, particularly those in show business, attempts to mask them:
Concealment Tactics: Actors and singers often use high collars, scarves, or gloves to hide wrinkled necks and hands [02:02].
Subtle Changes: I mention lesser-known facts, such as ears growing 0.51 millimeters per year [02:08].
The Nonlinear Process: Aging is a nonlinear experience where one might look young for a long time before aging visibly “overnight,” often triggered by illness [03:05].
Modern Obsessions and Acceptance
I critique the multi-billion dollar anti-aging industry and the “vanity” of seeking eternal youth [01:02].
The Myth of “Agelessness”: The author asserts that even practices like yoga cannot stop the visible signs of aging [02:36].
The Final Strategy: The “executive recipe” for old age is summarized as simply learning to live with it [02:53]. Instead of fighting a losing battle against nature, the takeaway is to embrace the process with humor and perspective [03:47].
Executive Tailpiece
The ER-100 human trial (NCT07290244) marks the first-ever clinical trial of a cellular rejuvenation therapy based on epigenetic reprogramming. Developed by Life Biosciences, ER-100 is designed to “reset” aged or damaged cells to a more youthful state. On January 28, 2026, the company announced that the FDA had cleared its Investigational New Drug (IND) application to begin this first-in-human study. However, it is only for advanced glaucoma patients to restore eye condition.
This experiment is an example of fiddling with the Yamanaka Factors. It is named after Dr. Shinya Yamanaka - who won the Nobel Prize in 2012 for discovering that aging in cells is reversible. He showed that epigenetic cells can be turned into an Induced Pluripotent Stem Cell (iPSC). This cell is "reset" to age zero and can be turned into a heart cell, nerve cell, or any other kind you can think of.
Why Is This a Big Deal?
Before this discovery, it was believed that cellular development was a “one-way street”—once a cell became a skin cell, it was stuck that way until it died. The Yamanaka factors proved that aging and cellular identity are reversible, opening the door to the entire field of regenerative medicine.
